中国实用内科杂志2025，Vol.45Issue(11)：910-912,3.DOI:10.19538/j.nk2025110104
内脏脂肪相关心血管代谢性疾病的风险筛查与干预管理
Risk screening and interventional management of cardiometabolic diseases related to visceral adiposity
摘要
Abstract
Visceral adipose tissue has emerged as a critical factor in cardiometabolic diseases,yet its role remains underrecognized in current prevention and management system.Conventional approaches often regard blood pressure,glucose,and lipid levels as the core factors,neglecting abnormal fat distribution as an upstream risk factor.The main barrier to visceral adipose tissue management is not the lack of diagnostic tools but insufficient awareness of risk recognition and proactive evaluation.Strengthening physician education and training,promoting the use of visceral adiposity indices and imaging-based perirenal fat assessment,and advancing development of novel diagnosis,medicines and devices targeting visceral adipose tissue may enhance early detection and prevention of cardiometabolic diseases.The patients with abdominal obesity,normal-weight obesity,or metabolic abnormalities without typical conventional indicators should undergo routine visceral adipose tissue-related risk evaluation and management.关键词
内脏脂肪/代谢性疾病/风险筛查/干预Key words
visceral adipose tissue/metabolic disease/risk screening/intervention分类
医药卫生引用本文复制引用
刘静,孔祥清..内脏脂肪相关心血管代谢性疾病的风险筛查与干预管理[J].中国实用内科杂志,2025,45(11):910-912,3.基金项目
国家重点研发计划(2023YFC2410500) （2023YFC2410500）
四大慢病重大专项(2024ZD0527300) （2024ZD0527300）
